Qantas expects to start international flights in October


In this Feb. 26, 2015, file photo, a Qantas plane maneuvers behind another parked at a gate at Sydney Airport in Sydney. Qantas Airways chief executive Alan Joyce said on Thursday, Feb. 25, 2021, he doesn't expect his airline will resume international travel except for New Zealand until late October, after the Australian population is vaccinated for COVID-19. (AP Photo/Rick Rycroft, File)

CANBERRA, Australia (AP) — Qantas Airways does not expect to resume international travel apart from New Zealand until late October after the Australian population is vaccinated for COVID-19, the airline’s chief executive said on Thursday.

The Sydney-based airline had been selling seats on international flights from July 1.

But there has been a huge surge in COVID-19 cases around the world since those July flights went on sale in early January, Qantas chief executive Alan Joyce said. There were also new coronavirus variants emerging.

Those tickets sold for flights after July 1 and before Oct. 31 are being refunded.

“We are now planning for international travel to restart at the end of October this year in line with the day for Australia’s vaccine rollout to be effectively complete,” Joyce said.

Australia’s immunization program began this week. The government expects vaccine will be made available to anyone who wants it by October.

But Australia plans to administer a second dose of the AstraZeneca vaccine 12 weeks after the first. The wait between doses of the Pfizer product is only 3-to-4 weeks. So some of those taking AstraZenca might not be effectively vaccinated by the end of October.

Qantas still expected a “material increase” in flights between Australia and New Zealand by July, Joyce said.

The Australian government would have final say on the resumption of international travel and would take into account issues including the effectiveness of vaccines on reducing virus transmission, Joyce said.

“We’re confident that there should be a good case for it opening up in October,” he said.

Australia has banned its citizens from leaving the country except under limited circumstances in a bid to prevent them bringing home infections. Most of Australia’s COVID-19 cases were infected overseas and are diagnosed during 14-days hotel quarantine which are mandatory for travelers on arrival.


Qantas on Thursday posted a 1.47 billion Australian dollar ($1.17 billion) statutory loss for the six months through December and a AU$6.9 billion ($5.5 billion) fall in revenue due to pandemic restrictions.

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Qantas Airways (QAN)
0 of 5 stars
A$0.00-100.0%N/AN/A
Pfizer (PFE)
4.995 of 5 stars
$26.26-0.2%6.40%72.94Hold$36.33
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

7 Stocks to Help You Build Off January’s Gains

7 Stocks to Help You Build Off January’s Gains

It's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.

Search Headlines: